Increased abundance of Ruminococcus gnavus in gut microbiota is associated with moyamoya disease and non-moyamoya intracranial large artery disease

[1]  S. Kuroda,et al.  Differentiation of Fibroblasts Into Myofibroblasts in the Arachnoid Membrane of Moyamoya Disease , 2022, Stroke.

[2]  S. Akira,et al.  The microsomal prostaglandin E synthase-1/PGE2 axis induces recovery from ischemia via recruitment of regulatory T cells. , 2022, Cardiovascular research.

[3]  Meng Huang,et al.  Gut microbiome is associated with metabolic syndrome accompanied by elevated gamma-glutamyl transpeptidase in men , 2022, Frontiers in Cellular and Infection Microbiology.

[4]  Jingfeng Chen,et al.  Comparison Of The Gut Microbiota In Different Age Groups In China , 2022, Frontiers in Cellular and Infection Microbiology.

[5]  Yuzhu Yan,et al.  Associations of gut microbiota with dyslipidemia based on sex differences in subjects from Northwestern China , 2022, World journal of gastroenterology.

[6]  Zhonghua Liu,et al.  Fermentation characteristics and probiotic activity of a purified fraction of polysaccharides from Fuzhuan brick tea , 2022, Food Science and Human Wellness.

[7]  S. Kuroda,et al.  2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society , 2022, Neurologia medico-chirurgica.

[8]  Dhwani K. Desai,et al.  Microbiome differential abundance methods produce different results across 38 datasets , 2022, Nature Communications.

[9]  Y. Okada,et al.  Dysbiosis of Gut Microbiome Is Associated With Rupture of Cerebral Aneurysms , 2021, Stroke.

[10]  S. Kuroda,et al.  Genetic and nongenetic factors for contralateral progression of unilateral moyamoya disease: the first report from the SUPRA Japan Study Group. , 2021, Journal of neurosurgery.

[11]  Y. Okada,et al.  Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese , 2021, Annals of the Rheumatic Diseases.

[12]  Y. Mineharu,et al.  RNF213 and GUCY1A3 in Moyamoya Disease: Key Regulators of Metabolism, Inflammation, and Vascular Stability , 2021, Frontiers in Neurology.

[13]  Huijie Jiang,et al.  Dysbiosis of Gut Microbiota in Patients With Acute Myocardial Infarction , 2021, Frontiers in Microbiology.

[14]  Elsje G. Otten,et al.  Ubiquitylation of lipopolysaccharide by RNF213 during bacterial infection , 2021, Nature.

[15]  S. Forslund,et al.  The Gut Microbiome in Hypertension: Recent Advances and Future Perspectives. , 2021, Circulation research.

[16]  N. Nagarajan,et al.  Ectopic gut colonization: a metagenomic study of the oral and gut microbiome in Crohn’s disease , 2021, Gut Pathogens.

[17]  Haifeng Lu,et al.  Periodontitis in elderly patients with type 2 diabetes mellitus: impact on gut microbiota and systemic inflammation , 2020, Aging.

[18]  M. Matsuhashi,et al.  Cortical Distribution of Fragile Periventricular Anastomotic Collateral Vessels in Moyamoya Disease: An Exploratory Cross-Sectional Study of Japanese Patients with Moyamoya Disease , 2020, American Journal of Neuroradiology.

[19]  Y. Bao,et al.  A metagenome-wide association study of gut microbiome and visceral fat accumulation , 2020, Computational and structural biotechnology journal.

[20]  Wenjing Zhao,et al.  Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross‐cohort microbial signatures and potential therapeutic target , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  G. Hu,et al.  Angiogenin maintains gut microbe homeostasis by balancing α-Proteobacteria and Lachnospiraceae , 2020, Gut.

[22]  L. Lerman,et al.  Coronary artery disease is associated with an altered gut microbiome composition , 2020, PloS one.

[23]  Yong Zhou,et al.  The Impact of Moyamoya Disease and RNF213 Mutations on the Spectrum of Plasma Protein and MicroRNA , 2019, Journal of clinical medicine.

[24]  H. Vlamakis,et al.  Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide , 2019, Proceedings of the National Academy of Sciences.

[25]  S. Esposito,et al.  The Gut Microbiota-Host Partnership as a Potential Driver of Kawasaki Syndrome , 2019, Front. Pediatr..

[26]  B. Rovin,et al.  Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal , 2019, Annals of the rheumatic diseases.

[27]  J. Raes,et al.  The neuroactive potential of the human gut microbiota in quality of life and depression , 2019, Nature Microbiology.

[28]  悌二 冨永,et al.  もやもや病（ウイリス動脈輪閉塞症）診断・治療ガイドライン（改訂版） , 2018 .

[29]  S. Miyamoto,et al.  Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease , 2017, PloS one.

[30]  S. Miyamoto,et al.  Significant Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease. , 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[31]  Kazumichi Yoshida,et al.  Periventricular anastomosis in moyamoya disease: detecting fragile collateral vessels with MR angiography. , 2016, Journal of neurosurgery.

[32]  Masafumi Sanefuji,et al.  Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells , 2015, Scientific Reports.

[33]  Seung-Chyul Hong,et al.  Adult Moyamoya Disease: A Burden of Intracranial Stenosis in East Asians? , 2015, PloS one.

[34]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[35]  S. Hyun,et al.  Neovascularization Precedes Occlusion in Moyamoya Disease: Angiographic Findings in 172 Pediatric Patients , 2014, European Neurology.

[36]  Y. Belkaid,et al.  Role of the Microbiota in Immunity and Inflammation , 2014, Cell.

[37]  Mihai Pop,et al.  Robust methods for differential abundance analysis in marker gene surveys , 2013, Nature Methods.

[38]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[39]  A. Munshi,et al.  Association of LPL gene variant and LDL, HDL, VLDL cholesterol and triglyceride levels with ischemic stroke and its subtypes , 2012, Journal of the Neurological Sciences.

[40]  J. Nicholson,et al.  Host-Gut Microbiota Metabolic Interactions , 2012, Science.

[41]  A. Koizumi,et al.  Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. , 2012, Neurologia medico-chirurgica.

[42]  K. Honda,et al.  The microbiome in infectious disease and inflammation. , 2012, Annual review of immunology.

[43]  A. Yamamoto,et al.  Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). , 2012, Neurologia medico-chirurgica.

[44]  A. Fujiyama,et al.  Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development , 2011, PloS one.

[45]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[46]  C. Huttenhower,et al.  Host and gut microbiota symbiotic factors: lessons from inflammatory bowel disease and successful symbionts , 2011, Cellular microbiology.

[47]  S. Kuroda,et al.  Moyamoya disease: current concepts and future perspectives , 2008, The Lancet Neurology.

[48]  K. Nozaki,et al.  Autosomal dominant moyamoya disease maps to chromosome 17q25.3 , 2008, Neurology.

[49]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[50]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[51]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[52]  M. Aoyagi,et al.  Increase in Prostaglandin E2 Production by Interleukin-1β in Arterial Smooth Muscle Cells Derived From Patients With Moyamoya Disease , 1999 .

[53]  S. Miyamoto,et al.  Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. , 1998, Journal of neurosurgery.

[54]  T. Kudo.  Spontaneous occlusion of the circle of Willis , 1968, Neurology.